-
公开(公告)号：US09815886B2
公开(公告)日：2017-11-14
申请号：US14592727
申请日：2015-01-08
申请人： ADMA Biologics, Inc.
IPC分类号： A61K39/42 , C07K16/06 , A61K39/395 , C07K16/08 , C07K16/10 , A61K45/06 , G01N33/68 , C07K16/12 , A61K39/155 , A61K39/00
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20210130441A1
公开(公告)日：2021-05-06
申请号：US16901993
申请日：2020-06-15
申请人： ADMA Biologics, Inc.
IPC分类号： C07K16/06 , A61K39/395 , A61K39/42 , C07K16/08 , C07K16/10 , A61K39/155 , A61K45/06 , G01N33/68 , C07K16/12
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US09969793B2
公开(公告)日：2018-05-15
申请号：US15811486
申请日：2017-11-13
申请人： ADMA Biologics, Inc.
IPC分类号： A61K39/42 , C07K16/06 , A61K39/395 , A61K45/06 , C07K16/08 , C07K16/10 , C07K16/12 , G01N33/68 , A61K39/155 , A61K39/00
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20160115221A1
公开(公告)日：2016-04-28
申请号：US14790872
申请日：2015-07-02
申请人： ADMA Biologics, Inc.
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US09714283B2
公开(公告)日：2017-07-25
申请号：US14790872
申请日：2015-07-02
申请人： ADMA Biologics, Inc.
IPC分类号： A61K39/395 , C07K16/06 , A61K39/42 , C07K16/08 , C07K16/10 , A61K45/06 , G01N33/68 , C07K16/12 , A61K39/155 , A61K39/00
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20180258159A1
公开(公告)日：2018-09-13
申请号：US15978692
申请日：2018-05-14
申请人： ADMA Biologics, Inc.
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20180086818A1
公开(公告)日：2018-03-29
申请号：US15811486
申请日：2017-11-13
申请人： ADMA Biologics, Inc.
IPC分类号： C07K16/06 , A61K39/395 , A61K39/42 , A61K45/06 , C07K16/08 , C07K16/10 , C07K16/12 , G01N33/68
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20160114037A1
公开(公告)日：2016-04-28
申请号：US14592727
申请日：2015-01-08
申请人： ADMA Biologics, Inc.
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , A61K2039/507 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , G01N33/6854 , Y02A50/466 , Y02A50/469
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
摘要翻译： 本发明涉及用于治疗免疫缺陷（例如原发性免疫缺陷病）的组合物和方法。 特别地，本发明提供了包含对多种呼吸道病原体特异的选择性抗体滴度的人血浆免疫球蛋白组合物，鉴定用于组合物中的人供体和供体样品的方法，制备组合物的方法和使用组合物的方法（例如， ，用于预防性给药和/或治疗性治疗（例如，被动免疫（例如，免疫预防）））。
-
公开(公告)号：US11780906B2
公开(公告)日：2023-10-10
申请号：US17750470
申请日：2022-05-23
申请人： ADMA Biologics, Inc.
IPC分类号： A61K39/395 , C07K16/06 , A61K39/42 , C07K16/08 , C07K16/10 , A61K39/155 , A61K45/06 , G01N33/68 , C07K16/12 , A61K39/00
CPC分类号： C07K16/06 , A61K39/155 , A61K39/39516 , A61K39/42 , A61K45/06 , C07K16/08 , C07K16/10 , C07K16/1009 , C07K16/1027 , C07K16/1203 , C07K16/1232 , C07K16/1242 , C07K16/1271 , C07K16/1275 , C07K16/1282 , C07K16/1285 , C07K16/1289 , G01N33/6854 , A61K2039/507 , C07K2317/10 , C07K2317/21 , C07K2317/31 , C07K2317/76 , Y02A50/30
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
公开(公告)号：US20220403008A1
公开(公告)日：2022-12-22
申请号：US17750470
申请日：2022-05-23
申请人： ADMA Biologics, Inc.
IPC分类号： C07K16/06 , A61K39/395 , A61K39/42 , C07K16/08 , C07K16/10 , A61K39/155 , A61K45/06 , G01N33/68 , C07K16/12
摘要： The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.023 秒)
